Liver Disease

Latest News

Patient in the hospital - Tyler Olson -stock.adobe.com.jpg
New Study Finds Risk Groups, Outpatient Care Barriers in Chronic Liver Disease

November 20th 2024

Patients with chronic liver disease who were unable to establish care were 85% more likely to require recurrent hospitalizations. This group included a disproportionate number of women and individuals with physical limitations affecting their health.

Blue FDA approved stamp | Imaged credit: Olivier Le Moal - stock.adobe.com
FDA Approves Resmetirom, First Treatment for NASH With Liver Fibrosis

March 14th 2024

AJMC
Statin Prescribing Patterns in Patient-Centered Medical Home Patients With NAFLD

August 17th 2023

Impact of Direct-Acting Antiviral Use for Chronic Hepatitis C on Health Care Costs in Medicaid: Economic Model Update

December 12th 2022

liver
Pathological Neutrophil Migration in Cirrhosis Linked to Increased Risk of AEs

November 30th 2022

Continuing Medical Education
View All
July 1st 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
July 1st 2025

Managed Care Insights on the Advances in the Eosinophilic Esophagitis Treatment Landscape

1.0 Credit / Gastroenterology, Immunology, Rare Diseases
July 1st 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health
July 1st 2025

Navigating the Changing Treatment Paradigm of Metabolic Dysfunction-Associated Steatohepatitis: A Guide for Managed Care Pharmacists

1.5 Credits / Endocrinology, Diabetes & Metabolism, Gastroenterology
July 1st 2025

Emerging Treatment Options for Inflammatory Bowel Disease: A Focus on IL-23 Pathway Inhibition

1.5 Credits / Gastroenterology, Immunology
July 1st 2025

Transforming Metabolic Dysfunction-Associated Steatohepatitis Management: Pharmacist Considerations for the Evolving Treatment Landscape

1.5 Credits / Gastroenterology
July 1st 2025

Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care Approaches

1.5 Credits / Gastroenterology, Immunology

More News

liver doctor
November 25th 2021

Improved Outcomes Have Decreased Liver Transplant Urgency for Some Patients With HCC

Laura Joszt, MA
Better risk stratification can help prioritize patients with hepatocellular carcinoma on the transplant waitlist who have higher risk disease.
fatty liver
November 23rd 2021

Improving Early Detection of Nonalcoholic Steatohepatitis on Ultrasound

Rose McNulty
A recent study aims to improve evaluation of fatty liver in ultrasound scans to increase hepatology referrals and predict significant liver fibrosis.
almonds
November 20th 2021

Study Evaluates Link Between Diet, Hepatic Health

Gianna Melillo
Findings from a cross-sectional study revealed a potential link between liver health and inflammatory diet properties.
Obese person working out
November 18th 2021

Bariatric Surgery Reduced Risk of Major Adverse Liver, CV Outcomes in Patients With NASH

Laura Joszt, MA
Patients with nonalcoholic steatohepatitis (NASH) and obesity had a reduced risk of major adverse liver outcomes and major adverse cardiovascular (CV) events after they underwent bariatric surgery compared with patients who did not have surgery.
High Iron Levels in Blood Linked to Increased Risk of Liver Cancer in NAFLD
November 12th 2021

High Iron Levels in Blood Linked to Increased Risk of Liver Cancer in NAFLD

Allison Inserro
Researchers conducted the study because although prior research has illustrated that elevated levels of iron in the blood from hereditary hemochromatosis can raise the risk of liver cancer, little is known about the effect of this condition in nonalcoholic fatty liver disease (NAFLD).
Global health
November 10th 2021

NAFLD Is a Growing Driver of Chronic Liver Disease and Related Deaths

Laura Joszt, MA
An evaluation of data from the Global Burden of Disease found that nonalcoholic fatty liver disease (NAFLD) is a main driver of chronic liver disease and has increased among adolescents and young adults.
Pediatric medicine
November 5th 2021

Children With HCC Have Higher Waitlist Mortality for Liver Transplant Than Children With HBL

Laura Joszt, MA
The higher waitlist mortality for liver transplant among children with hepatocellular carcinoma (HCC) compared with hepatoblastoma (HBL) indicates a need to improve prioritization for children with HCC.
Physical Activity Protects Against NAFLD, Study Suggests
October 30th 2021

Physical Activity Protects Against NAFLD, Study Suggests

Christine Blank
Male doctor and male patient
October 27th 2021

Inaugural Report Provides Insight Into Management and Trends of Chronic Liver Disease

Laura Joszt, MA
The incidence of chronic liver disease is expected to sharply rise by 2030, making it important to understand the factors that influence patient outcomes.
Outcomes and Mortality Risks in Patients With NAFLD
October 22nd 2021

Outcomes and Mortality Risks in Patients With NAFLD

Laura Joszt, MA
Mortality and liver-related complications increased with fibrosis stage in patients with nonalcoholic fatty liver disease (NAFLD).
Tremelimumab Added to Durvalumab Shows Positive Results in HCC
October 15th 2021

Tremelimumab Added to Durvalumab Shows Positive Results in HCC

Allison Inserro
There was statistically significant and clinically meaningful overall survival benefit vs sorafenib as a first-line treatment for patients with unresectable hepatocellular carcinoma (HCC) in top-line results from a phase 3 trial.
Coffee
October 11th 2021

Coffee Consumption Associated With Less Liver Stiffness

Laura Joszt, MA
Individuals who drink more than 3 cups of coffee a day had decreased liver stiffness.
Clinical Care Pathway Released for NAFLD, NASH
October 9th 2021

Clinical Care Pathway Released for NAFLD, NASH

Allison Inserro
The pathway outlines a 4-step screening process for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).
Europe map
October 8th 2021

Examining Differences in Liver Cancer Incidence Across 7 Countries

AJMC Staff
Comparing liver cancer survival across high-income countries has been difficult due to different standard and coding practices
FDA Approves Maralixibat to Treat Rare Pediatric Liver Disease
October 1st 2021

FDA Approves Maralixibat to Treat Rare Pediatric Liver Disease

Laura Joszt, MA
Maralixibat is the first treatment approved for cholestatic pruritus in patients with Alagille syndrome who are 1 year or older.
Image of hepatitis virus
September 29th 2021

Treatment for Chronic Hepatitis in Pediatric Cases Remains Suboptimal

Jaime Rosenberg
Findings from this new study are the result of an investigation into over 360 children, many with active hepatitis, elevated alanine aminotransferase levels, and an immune active phenotype.
Doctor checking the liver
September 24th 2021

Prognostic Nutritional Index May Be Associated With Survival in HCC

Jaime Rosenberg
Researchers argue that Onodera’s prognostic nutritional index, calculated by lymphocytes and serum albumin to determine nutritional and immune status, is a straightforward method for use among patients undergoing liver surgery.
Predicting Which Patients Will Develop HCC After HCV Treatment
September 19th 2021

Predicting Which Patients Will Develop HCC After HCV Treatment

Laura Joszt, MA
Patients who are treated with direct-acting antivirals to treat hepatitis C virus (HCV) are still at risk of developing hepatocellular carcinoma (HCC).
Liver Cancer Rising in Rural Parts of the United States
September 19th 2021

Liver Cancer Rising in Rural Parts of the United States

AJMC Staff
Although some cancers are falling for rural US residents, liver cancer is on the rise, a new study has found.
Patients With Chronic Liver Diseases Have High Risk of More Severe COVID-19 Outcomes
September 14th 2021

Patients With Chronic Liver Diseases Have High Risk of More Severe COVID-19 Outcomes

Laura Joszt, MA
Patients with chronic liver diseases have been at a high risk of more severe COVID-19 outcomes, but the pandemic has meant the management of these diseases has received less attention.
Picture of operating room
September 11th 2021

Poorly Differentiated Tumor Size Linked to Worse Prognosis in HCC, Study Finds

Allison Inserro
Investigators examined medical records spanning 3 decades to look at the effect of poorly differentiated tumor size on outcomes in survival in hepatocellular carcinoma (HCC).
Image of a fatty liver
September 9th 2021

Children, Adolescents Considered Obese May Have Greater Risk of NAFLD

Maggie L. Shaw
This new study from investigators at Tel Aviv University looked at predictors of nonalcoholic fatty liver disease (NAFLD) among children and adolescents considered obese, because its predictors are not well known in this group.
Doctor team
September 4th 2021

Multidisciplinary Approach Important for Successful HCC Care

Laura Joszt, MA
Hepatocellular carcinoma (HCC) is challenging to diagnose and has an evolving treatment landscape, which makes a multidisciplinary approach to care important to ensure high-quality care and the best patient outcomes.
stethoscope on American flag
September 3rd 2021

Study Underscores the Impact of Socioeconomic Status on HCC Prognosis

Gianna Melillo
Research shows how socioeconomic status can affect prognosis among patients with hepatocellular carcinoma (HCC).
liver graphic
August 28th 2021

Analysis Reveals Negative Mental Health Among Those With HCC Diagnosis

Gianna Melillo
Results of a score-matched analysis showed individuals with hepatocellular cancer reported poor mental health as time progressed after diagnosis.
Liquid Biopsy to Detect Early-Stage Liver Cancer Shows Higher Sensitivity, Specificity
August 26th 2021

Liquid Biopsy to Detect Early-Stage Liver Cancer Shows Higher Sensitivity, Specificity

Allison Inserro
Researchers said the blood test offers an earlier warning of hepatocellular carcinoma than current methods.
Researchers Highlight Promise of AI in Diagnosing, Managing NAFLD
August 20th 2021

Researchers Highlight Promise of AI in Diagnosing, Managing NAFLD

Allison Inserro
Sifting through large quantities of data using artificial intelligence (AI) could one day change how nonalcoholic fatty liver disease (NAFLD) is diagnosed, managed, and treated, according to a recent review.
Exposure to Dust at the World Trade Center Linked to Liver Disease in Early Responders
August 15th 2021

Exposure to Dust at the World Trade Center Linked to Liver Disease in Early Responders

Laura Joszt, MA
Early responders to the World Trade Center after the 9/11 attacks are associated with a higher likelihood of liver disease, according to a long-term follow-up of responders.
dna graphic
August 11th 2021

Researchers Uncover Shared Genes Among NAFLD, Hypertension

Jaime Rosenberg
Using a systems biology approach, the researchers discovered 64 genes shared between non-alcoholic fatty liver disease (NAFLD) and hypertension, considered to be core genes for the 2 conditions.
diet and exercise
August 9th 2021

Approaching NAFLD Management With a Multidisciplinary Clinic Model

Laura Joszt, MA
Multidisciplinary care is an ideal way to management non-alcoholic fatty liver disease (NAFLD) because it is a complex disease associated with numerous comorbidities and necessitating lifestyle changes.
<123>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo